Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
81,100
-300 (-0.37%)
Last updated: Sep 9, 2025, 2:08 PM KST
KRX:185750 Market Cap
KRX:185750 has a market cap or net worth of 1.07 trillion as of September 8, 2025. Its market cap has decreased by -29.33% in one year.
Market Cap
1.07T
Enterprise Value
1.06T
Revenue
1.66T
Ranking
n/a
PE Ratio
17.61
Stock Price
81,100.00
Market Cap Chart
Since December 6, 2013, KRX:185750's market cap has increased from 677.45B to 1.07T, an increase of 58.32%. That is a compound annual growth rate of 3.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 1,072.53B | -9.03% |
Dec 30, 2024 | 1,178.98B | -29.22% |
Dec 28, 2023 | 1,665.71B | 66.27% |
Dec 29, 2022 | 1,001.82B | -23.66% |
Dec 30, 2021 | 1,312.27B | -49.00% |
Dec 30, 2020 | 2,572.97B | 145.08% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.31T |
Celltrion | 37.23T |
ALTEOGEN | 25.41T |
Yuhan | 8,902.27B |
SK Biopharmaceuticals | 8,551.81B |
Peptron | 7,070.75B |
PharmaResearch | 6,545.48B |
ABL Bio | 5,621.23B |